An early rise in urine N-telopeptide predicts the growth response of normal prepubertal short children to growth hormone therapy

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue 5, 1996, Pages 519-521

  Phillip, M ^a,c   Hershkovitz, E ^a   Limoni, Y ^a   Leiberman, E ^a   Belotserkovsky, O ^a   Douvdevani, A ^a   Weber, D ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Endocrine Sciences   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bone turnover; Growth hormone; Growth response; N telopeptide; Osteocalcin; Pyridinium cross links

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN; GROWTH HORMONE; HUMAN GROWTH HORMONE; OSTEOCALCIN; PEPTIDE; RECOMBINANT GROWTH HORMONE;

ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CROSS LINKING; GROWTH; HUMAN; PREPUBERTY; REGRESSION ANALYSIS; SCHOOL CHILD; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

EID: 0029906584     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1996.9.5.519     Document Type: Article

References (7)

1. Delmas PD. Biochemical markers for bone turnover. J Bone Min Res 1993; 8 (Suppl 2): S549-S555.
2. Eyre D. Editorial: New biomarkers of bone resorption. J Clin Endocrinol Metab 1992; 74: 470A-470C.
3. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachmann M, Christiansen C. Serum bone Gla protein: A potential marker of growth hormone deficiency and the response to growth hormone therapy. J Clin Endocrinol Metab 1990; 71: 122-126.
4. Kanzaki S, Hosoda K, Moriwake T, Tanaka H, Kubo T, Inoue M, Higuchi J, Yamaji T, Seino Y. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: A potential marker of bone growth and response to GH therapy. J Clin Endocrinol Metab 1992; 75: 1104-1109.
5. Fujimoto S, Kubo T, Tanaka H, Miura M, Seino Y. Urinary pyridinoline and deoxypuridinoline in healthy children and in children with growth hormone deficiency. J Clin Endocrinol Metab 1995; 80: 1922-1928.
6. Sartorio A, Conti A, Guzzaloni G, Faglia G. Serum osteocalcin levels in patients with GH deficiency before and during GH treatment. Acta Paediatr Scand 1991; 80: 100-102.
7. Markovitz ME, Dimartino-Nardi J, Gasparini F, Fishman K, Rosen JF, Saenger P. Effects of GH therapy on circadian osteocalcin rhythms in idiopathic short stature. J Clin Endocrinol Metab 1989; 64: 420-425.